Your browser is no longer supported. Please, upgrade your browser.
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E24.78 EPS (ttm)6.69 Insider Own0.08% Shs Outstand2.67B Perf Week1.15%
Market Cap435.48B Forward P/E16.03 EPS next Y10.34 Insider Trans0.00% Shs Float2.63B Perf Month1.58%
Income17.88B PEG3.05 EPS next Q2.13 Inst Own69.60% Short Float0.62% Perf Quarter-3.73%
Sales91.45B P/S4.76 EPS this Y-4.20% Inst Trans0.17% Short Ratio2.77 Perf Half Y2.33%
Book/sh26.04 P/B6.37 EPS next Y5.59% ROA8.70% Target Price188.82 Perf Year15.13%
Cash/sh9.63 P/C17.21 EPS next 5Y8.12% ROE23.00% 52W Range133.65 - 179.92 Perf YTD5.32%
Dividend4.24 P/FCF42.62 EPS past 5Y-0.30% ROI14.60% 52W High-8.97% Beta0.71
Dividend %2.56% Quick Ratio1.10 Sales past 5Y3.30% Gross Margin67.60% 52W Low22.54% ATR2.26
Employees134500 Current Ratio1.40 Sales Q/Q27.10% Oper. Margin19.00% RSI (14)51.24 Volatility1.14% 1.43%
OptionableYes Debt/Eq0.48 EPS Q/Q72.70% Profit Margin16.50% Rel Volume0.72 Prev Close165.75
ShortableYes LT Debt/Eq0.44 EarningsOct 19 BMO Payout70.40% Avg Volume5.90M Price163.78
Recom2.10 SMA201.40% SMA50-1.83% SMA200-1.25% Volume3,299,773 Change-1.19%
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $187
May-28-21Resumed Morgan Stanley Overweight $187
Apr-28-20Downgrade UBS Buy → Neutral $163 → $160
Apr-22-20Upgrade BofA/Merrill Neutral → Buy $150 → $175
Mar-05-20Initiated Citigroup Buy $163
Dec-19-19Upgrade Barclays Equal Weight → Overweight $173
Dec-17-19Upgrade Morgan Stanley Equal-Weight → Overweight $145 → $170
Nov-20-19Initiated Cantor Fitzgerald Overweight $160
Oct-16-19Upgrade Atlantic Equities Underweight → Neutral
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-27-21 11:18AM  
11:10AM  
11:06AM  
Oct-26-21 06:23PM  
05:20PM  
10:16AM  
07:00AM  
06:20AM  
05:52AM  
Oct-25-21 06:10PM  
12:55PM  
12:15PM  
11:48AM  
09:00AM  
08:54AM  
07:40AM  
06:50AM  
06:20AM  
Oct-23-21 10:26AM  
07:01AM  
06:01AM  
Oct-22-21 06:58PM  
06:48PM  
05:01PM  
04:15PM  
03:01PM  
02:22PM  
01:40PM  
12:07PM  
10:15AM  
10:14AM  
10:08AM  
10:06AM  
09:46AM  
09:05AM  
08:42AM  
08:40AM  
08:17AM  
07:49AM  
06:20AM  
Oct-21-21 09:05PM  
07:48PM  
07:48PM  
06:12PM  
04:08PM  
04:03PM  
04:00PM  
03:36PM  
02:38PM  
01:31PM  
12:44PM  
12:33PM  
12:24PM  
11:57AM  
11:17AM  
11:06AM  
10:35AM  
10:21AM  
09:40AM  
09:26AM  
09:25AM  
08:45AM  
07:32AM  
Oct-20-21 07:28PM  
06:38PM  
06:31PM  
05:40PM  
05:19PM  
05:08PM  
05:08PM  
02:39PM  
01:14PM  
12:10PM  
12:09PM  
12:06PM  
09:21AM  
09:14AM  
09:07AM  
08:46AM  
06:52AM  
06:40AM  
05:58AM  
05:52AM  
01:35AM  
Oct-19-21 04:54PM  
04:28PM  
04:05PM  
03:35PM  
03:11PM  
03:10PM  
03:06PM  
02:35PM  
02:34PM  
02:00PM  
12:31PM  
12:11PM  
12:10PM  
11:15AM  
11:13AM  
10:46AM  
Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; smoking cessation products under the NICORETTE brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides electrophysiology products to treat cardiovascular diseases and neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusVice Chair, Exec CommitteeFeb 12Option Exercise0.0035,0620289,864Feb 17 07:09 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 12Option Exercise0.0013,6060121,191Feb 17 07:09 PM
Ullmann Michael HExec VP, General CounselFeb 12Option Exercise0.0014,4440157,728Feb 17 07:09 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 12Option Exercise0.0010,362068,837Feb 17 07:09 PM
Wolk Joseph JExec VP, CFOFeb 12Option Exercise0.005,086024,513Feb 17 07:09 PM
Decker Robert JController, CAOFeb 12Option Exercise0.001,310014,701Feb 17 07:09 PM
Gorsky AlexChairman, CEOFeb 12Option Exercise0.0075,1050507,925Feb 17 07:09 PM
Mongon ThibautExec VP, WW Chair, ConsumerFeb 12Option Exercise0.007,145042,960Feb 17 07:09 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 12Option Exercise0.0033,0210209,490Feb 17 07:09 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 12Option Exercise0.0012,8730113,039Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & CCOFeb 12Option Exercise0.009,211065,290Feb 17 07:09 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 12Option Exercise0.0013,136034,834Feb 17 07:09 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Option Exercise62.2054,6623,399,976110,741Dec 10 06:19 PM
Sneed Michael EEVP, Global Corp Aff & COODec 09Sale152.9354,6628,359,46056,079Dec 10 06:19 PM